Related Experiment Video

Updated: Aug 30, 2026

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry
11:23

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry

Published on: May 22, 2012

Flow cytometric DNA analysis of human cancer cell lines

Peter Mullen1

  • 1Cancer Research UK Oncology Unit, Western General Hospital, Edinburgh, UK.

Methods in Molecular Medicine
|November 25, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

Related Experiment Videos

Last Updated: Aug 30, 2026

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry
11:23

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry

Published on: May 22, 2012

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

Articles linked to this work by shared authors, journal, and citation graph.

Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment.

Cancers·2026

Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypes.

Npj imaging·2025

A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death.

PloS one·2025

Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine.

Translational oncology·2024

The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent.

Cancer chemotherapy and pharmacology·2023

Objective Supervised Machine Learning-Based Classification and Inference of Biological Neuronal Networks.

Molecules (Basel, Switzerland)·2022

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

Methods for generation of genetically modified fibroblasts for immunotherapy of cancer.

Methods in molecular medicine·2014

Artificial intelligence in prediabetes care: applications in screening, risk prediction, and lifestyle intervention.

Frontiers in endocrinology·2026

Case Report: Aumolertinib response as a diagnostic clue for intrapulmonary metastases.

Frontiers in oncology·2026

Correlation between atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion and cervical lesions: a retrospective analysis of opportunistic and organized cervical screening populations.

Frontiers in oncology·2026

BAP31 Drives Cartilage Calcification through Disruption of Autophagosome-Lysosome Fusion in Osteoarthritis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Signal Transducing Adaptor Protein-2 Represses Epithelial-Mesenchymal Transition by Downregulating SMAD-Mediated ZEB1 Expression.

Genes to cells : devoted to molecular & cellular mechanisms·2026

Lysine Oxidation by LOXL2 in Single Strands Versus Triple Helices: Implications for Collagen-Related Diseases.

Angewandte Chemie (International ed. in English)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us